Notice: You are viewing an unstyled version of this page. Are you using a very old browser? If so, please consider upgrading

PITCHES trial protocol published in BioMedCentral Trials

Published on Monday, 10 December 2018 Tweet

With no existing evidence to support the use of ursodeoxycholic acid (UDCA) to improve intrahepatic cholestasis of pregnancy (ICP), PITCHES, a Phase III clinical trial proposes to provide definitive evidence to discover if the use of UDCA improves pregnancy outcomes in women with this liver disorder.

For more information, please find the recently published study protocol for the PITCHES trial in the BioMedCentral Trials journal here.

Updated: Monday, 23 November 2020 12:00 (v6)